Viral Inactivation Market: Phenomenal Growth Ahead with $8.28 Billion Valuation by 2029

 The viral inactivation market has witnessed significant growth in recent years, escalating from $5.01 billion in 2024 to $5.48 billion in 2025 at a compound annual growth rate (CAGR) of 9.4%. The historical growth can be attributed to global air traffic growth, enhanced navigation capabilities, commercial aviation expansion, airline cost savings, improved flight safety, and reduction in pilot workload.

The market is expected to achieve robust growth in the upcoming years, reaching $8.28 billion in 2029 at a CAGR of 10.9%. The forecasted growth can be accredited to autonomous flight development, next-generation aircraft designs, efforts for sustainable aviation, urban air mobility (UAM), and increasing demand for aircraft. Driving trends in the forecast period include integration of advanced avionics, implementation of artificial intelligence, human-machine interface (HMI) innovations, retrofitting existing aircraft, and global navigation satellite system (GNSS) integration.

Get Your Free Sample of The Global Viral Inactivation Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10401&type=smp

What Are The Key Drivers Of The Viral Inactivation Market?
The viral inactivation market growth is mainly driven by growing instances of various infectious diseases. Infectious diseases that transmit from one person to another, via polluted foods and beverages, or through pathogens such as viruses, bacteria, fungi, and parasites drive the use of viral inactivation, which helps control the spread of contagious viral infections. For instance, according to the CDC, the number of tuberculosis cases increased from 8,320 in 2022 to 9,615 in 2023. Hence, the growing instances of infectious diseases are propelling the growth of the viral inactivation market.

How Is The Viral Inactivation Market Segmented?
The viral inactivation market segments are as follows:
- By Product: Kits And Reagents, Systems, Services
- By Method: Solvent Detergent Method, pH Adjustment Method, Pasteurization, Other Methods
- By Application: Vaccines And Therapeutics, Tissues And Tissue Products, Blood And Blood Products, Other Applications
- By End User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Blood Banks, Hospital, Academic Research Institutes, Other End Users

Order your report now for swift delivery:
https://www.thebusinessresearchcompany.com/report/viral-inactivation-global-market-report

Which Companies Are The Key Players In The Viral Inactivation Market?
Major companies operating in the viral inactivation market include  Merck & Co. Inc., Sartorius AG, Texcell SA, SGS SA, Charles River Laboratories Inc., Clean Cells SAS, Rad Source Technologies, WuXi AppTec, Sigma-Aldrich Co. LLC, Thermo Fisher Scientific Inc., Macopharma, Cerus Corporation, TERUMO BCT INC., Shandong Weigao Group Medical Polymer Co. Ltd., Pall Corporation and Eurofins Scientific, General Electric Company, Cytiva, Mettler Toledo, Viral Inactivated Plasma Systems SA, Eurofins Scientific SE, Lonza Group AG, Avantor Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG, Fujifilm Holdings Corporation, Pfizer Inc., Novartis AG, Gilead Sciences Inc., Johnson & Johnson Private Limited.

What Are The Emerging Trends In The Viral Inactivation Market Landscape?
A key trend gaining popularity in the viral inactivation market is the increasing implementation of technologically advanced processes. For instance, in March 2022, WuXi Advanced Therapies, a wholly-owned subsidiary of WuXi AppTec, launched Tetracycline-Enabled Self-Silencing Adenovirus (TESSA) Technology. This trend-setting technology facilitates the approval of new therapies through simultaneous assay formulation, biosafety, viral clearance, product release, and in-house testing.

Which Region Predicted To Have The Fastest Growth In The Viral Inactivation Market?
North America was the largest region in the viral inactivation market in 2024 while Asia-Pacific is projected to be the fastest-growing region in the global viral inactivation market. The regions covered in the viral inactivation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

What Does The Viral Inactivation Market Report 2025 Offer?
Viral inactivation refers to the process of inactivating viral contamination by exposing the bioprocess fluid to environments that denature the viral protein yet retain the active ingredient of the product. It is most commonly used in blood plasma processing and monoclonal antibody processing. The Viral Inactivation Market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.

Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10401

About The Business Research Company
The Business Research Company offers over 15000+ reports from 27 industries covering 60+ geographies and has built a reputation for offering comprehensive, data-rich research and insights. With 1,500,000 datasets, in-depth secondary research, and unique insights from industry leaders, you can keep ahead of the curve.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model